Research News for October 5, 2022
advertisement
- McQueen Awarded $600K to Develop Predictive Tool for Type-1 Diabetes
- Scutellaria baicalensis georgi is a promising candidate for the treatment of autoimmune diseases
- Calcitonin gene-related peptide is a potential autoantigen for CD4 T cells in type 1 diabetes
- Are off-target effects of imatinib the key to improving beta-cell function in diabetes? (Full text HTML, PDF)
- A Conductive Hydrogel Microneedle-Based Assay Integrating PEDOT:PSS and Ag-Pt Nanoparticles for Real-time, Enzyme-less, and Electrochemical Sensing of Glucose
- Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes
- Plasma-derived exosomal mRNA profiles associated with type 1 diabetes mellitus (Full text HTML, PDF)
- ER stress promotes mitochondrial DNA mediated type-1 interferon response in beta-cells and interleukin-8 driven neutrophil chemotaxis
- N- terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells (Full text HTML, PDF)
- Identification of novel differentially expressed genes in type 1 diabetes mellitus complications using transcriptomic profiling of UAE patients: a multicenter study
- Nanotechnology: Newer Approach in Insulin Therapy
- Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries
